Despite the fact that Wen et al suggested that FTO is downregulated in bladder urothelial carcinoma,19 which was a claim based on mRNA and protein analyses of tissue samples collected from a hospital patient and microarray cohort, we demonstrated that FTO is upregulated in the tumor xenografts obtained from bladder cancer patients. This evidence concerns the gene FTO and neoplasm.